Alejandro Galindo - 31 Jul 2022 Form 4/A - Amendment Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Issuer symbol
MNKD
Transactions as of
31 Jul 2022
Net transactions value
+$14,650
Form type
4/A - Amendment
Filing time
24 Aug 2022, 21:00:36 UTC
Date Of Original Report
01 Aug 2022
Previous filing
25 May 2022
Next filing
23 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock, $0.01 Par Value Award $14,650 +5,000 +0.64% $2.93 781,690 31 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective July 31, 2022.